William G. Wierda, MD, PhD^1*, Constantine S. Tam, MD², John N. Allan, MD³, Tanya Siddiqi, MD^4*, Thomas J. Kipps, MD, PhD⁵, Stephen Opat, FRACP, FRCPA, MBBS^6*, Alessandra Tedeschi, MD^7*, Xavier C. Badoux, MBBS, FRACP, FRCPA⁸, Bryone J. Kuss, MBBS, PhD, FRACP, FRCPA^9*, Sharon Jackson, MD^10*, Carol Moreno, MD, PhD^11*, Ryan Jacobs, MD^12*, John M. Pagel, MD, PhD¹³, Ian W. Flinn, MD, PhD¹⁴, Cathy Zhou, MS^15*, Edith Szafer-Glusman, PhD^15*, Joi Ninomoto, PharmD^15*, James P. Dean, MD, PhD¹⁵, Danelle F. James, MD, MAS¹⁵ and Paolo Ghia, MD, PhD¹⁶

¹Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
²Peter MacCallum Cancer Centre & St. Vincent’s Hospital and the University of Melbourne, Melbourne, VIC, Australia
³Weill Cornell Medicine, New York, NY
⁴City of Hope National Medical Center, Duarte, CA
⁵University of California, San Diego, Moores Cancer Center, La Jolla, CA
⁶Monash University, Clayton, VIC, Australia
⁷ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
⁸Ministry of Health, Kogarah, NSW, Australia
⁹Flinders University and Medical Centre, Bedford Park, SA, Australia
¹⁰Middlemore Hospital, Auckland, New Zealand
¹¹Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain
¹²Levine Cancer Institute, Charlotte, NC
¹³Fred Hutchinson Cancer Research Center, Seattle, WA
¹⁴Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN
¹⁵Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA
¹⁶Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy

Talha Munir, MBBS^1*, Rebecca H. Boucher, BSc, MSc, PhD^2*, Nichola Webster^3*, Surita Dalal, PhD^4*, Kristian Brock, PhD^2*, Francesca Yates, PhD^2*, Chhaya Sankhalpara^5*, Donald Macdonald, MBChB, MD, FRCP, PhD, FCRPath^6*, Christopher Fegan^7*, Alison McCaig, MBChB, FRCPath, PhD, MRCP^8*, Anna Schuh, MD⁹, Andrew Pettitt, MA, MB BChir, PhD, MRCP, MRCPath^10*, John G. Gribben, MD, DSc, FRCP, FMedSci, FRCPath¹¹, Piers Patten, MD, PhD¹², Stephen Devereux, PhD, FRCP, FRCPath, MRCPath, MB BS^12*, Adrian Bloor, PhD, FRCP, FRCPath^13*, Christopher P Fox, PhD, FRCPath, MRCP, MBChB^14*, Francesco Forconi, MD, PhD, FRCPath^15*, Andrew Rawstron, PhD^4* and Peter Hillmen, MBChB, PhD^16*

¹St James University Hospital, Leeds, United Kingdom
²Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom
³St James's University Hospital, Leeds, United Kingdom
⁴HMDS, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
⁵Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, ENG, United Kingdom
⁶Imperial College Healthcare NHS Trust, London, United Kingdom
⁷University Hospital of Wales, Cardiff, United Kingdom
⁸The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
⁹Oxford University Hospital NHT Trust, Oxford, United Kingdom
¹⁰Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom
¹¹Barts Cancer Institute, London, United Kingdom
¹²King’s College London and King’s College Hospital NHS Foundation Trust, London, United Kingdom
¹³The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom
¹⁴Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
¹⁵University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
¹⁶St. James's University Hospital, Institute of Oncology, Leeds, United Kingdom

Arnon P. Kater, MD, PhD¹, Thomas J. Kipps, MD, PhD², Barbara Eichhorst, MD³, Peter Hillmen, MBChB, PhD, FRCP, FRCPath⁴, James D'Rozario^5*, Carolyn Owen, MD FRCPC⁶, Sarit E Assouline, MD, MSc⁷, Nicole Lamanna, MD⁸, Tadeusz J. Robak^9*, Javier de la Serna^10*, Ulrich Jaeger¹¹, Guillaume Cartron, MD, PhD^12*, Marco Montillo¹³, Clemens Mellink^14*, Brenda J. Chyla¹⁵, Cameron Wilson^16*, Jenny Wu^17*, Yanwen Jiang^17*, Marcus Lefebure^16*, Michelle Boyer^16* and John F. Seymour, MBBS¹⁸

¹Cancer Center Amsterdam, Amsterdam, Netherlands
²UCSD Moores Cancer Center, San Diego, CA
³Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf, University of Cologne, Cologne, Germany
⁴St. James’s University Hospital, Leeds, United Kingdom
⁵The John Curtin School of Medical Research, Australian National University, Canberra, Australia
⁶University of Calgary, Calgary, Canada
⁷Segal Cancer Center, Lady Davis Institute, Jewish General Hospital, Montreal, Canada
⁸New York-Presbyterian/ Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center, New York, NY
⁹Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland
¹⁰Hospital Universitario 12 de Octubre, Madrid, Spain
¹¹Dept. of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
¹²Centre Hospitalier Universitaire de Montpellier, Montpellier, France
¹³Department of Haematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
¹⁴Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
¹⁵AbbVie Inc., North Chicago, IL
¹⁶Roche Products Ltd, Welwyn Garden City, United Kingdom
¹⁷Genentech, Inc., South San Francisco, CA
¹⁸Royal Melbourne Hospital, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia

Anthony R. Mato, MD¹, Stephen J. Schuster, MD², Francine M. Foss, MD³, Iris Isufi, MD³, Shalin K. Kothari, MD³, Wei Ding, MD, PhD⁴, Danielle M. Brander, MD⁵, Andrea Sitlinger, MD⁵, Allison C. Rosenthal, D.O.⁶, Jose F. Leis, MD, PhD⁷, Han W. Tun, MD⁸, Kaitlin Kennard, RN, BSN^2*, Allison R. Nelson, RN^2*, Victoria Falco, BSN^1*, Celina J. Komari, BS^1*, Amber B. Koehler, PA-C, MS^4*, Rachel Stowe, RN^5*, Wei He, PhD^9,10*, Albert Kearney, Ph.D.^9*, Min Gui, Ph.D.^9*, Tim McKinlay^9*, Lindsey E Roeker, MD¹, Meghan C. Thompson, MD¹ and Scott F. Huntington, MD, MPH³

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
³Yale Cancer Center, New Haven, CT
⁴Mayo Clinic, Rochester, MN
⁵Duke University Medical Center, Durham, NC
⁶Mayo Clinic, Phoenix, AZ
⁷Division of Hematology and Medical Oncology, Mayo Clinic Health System, Phoenix, AZ
⁸Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL
⁹Zhejiang DTRM Biopharma LLC, Plymouth Meeting, PA
¹⁰Zhejiang DTRM Biopharma Co. Ltd., Hangzhou Fuyang, China

Othman Al-Sawaf, MD^1*, Can Zhang, PhD^2*, Sandra Robrecht, PhD^3*, Cameron Wilson^4*, Maneesh Tandon, MD^5*, Travers Ching^6*, Anna-Maria Fink, MD^7*, Matthias Ritgen, MD^8*, Eugen Tausch, MD^9*, Karl-Anton Kreuzer, MD^2*, William Schary, PhD¹⁰, Clemens-Martin Wendtner^11*, Barbara Eichhorst, MD³, Stephan Stilgenbauer, MD¹², Yanwen Jiang^13*, Michael Hallek¹⁴ and Kirsten Fischer, MD^3*

¹University of Cologne, Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf, Cologne, Cologne, Germany
²Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf, German CLL Study Group, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany, Cologne, Germany
³Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf, University of Cologne, Cologne, Germany
⁴Roche Products Ltd, Welwyn Garden City, United Kingdom
⁵Roche Products Limited, Welwyn Garden City, United Kingdom
⁶Adaptive Biotechnologies, Seattle, WA
⁷University Hospital Cologne, Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf; Cologne, Cologne, Germany
⁸Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany
⁹Department of Internal Medicine III, Ulm University, Ulm, Germany
¹⁰AbbVie, North Chicago, IL
¹¹Klinikum Schwabing, Department I of Medicine, Academic Teaching Hospital of University of Munich, Munich, Germany
¹²Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany
¹³Genentech, Inc., South San Francisco, CA
¹⁴Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf and German CLL Study Group, University of Cologne, Cologne, Germany

Shuhua Yi, MD^1*, Jun Du^2*, Ying Yu^3*, Yang Jiao^4*, Yi Wang^5*, Huijun Wang^6*, Tingyu Wang^7*, Rui Lv^3*, Wei Liu^8*, Wenjie Xiong, PhD^9*, Huimin Liu^1*, Wenyang Huang^3*, Dehui Zou, MD^10*, Gang An^11*, Yaozhong Zhao^12*, Jianxiang Wang, MD⁶ and Lugui Qiu, MD³

¹lymphoma and myeloma center, National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
²Institute of Hematology and Blood Diseases Hospital, State Key Lab of Experimental Hematology, Chinese Academy of Medical, Science and Peking Union Medical College, Tianjin, China
³National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁴the Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China, tianjin, China
⁵State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, tianjin, China
⁶State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁷Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
⁸State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood, TIANJIN, China
⁹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, CHN
¹⁰State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, TIANJIN, China
¹¹Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
¹²Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences,Tianji, Tianjing, CHN